Back to FDA Applications sponsored by ANTARES PHARMA INC

FDA Drug Application 204824 by ANTARES PHARMA INC

Application Number204824
Application Type New Drug Application
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New manufacturer
Therapeutic Potential Standard
Orphan Code 

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP010/11/2013N37430000,204824Orig2s000_replace_ltr.pdf 10/16/2013
AP110/11/2013N37430000,204824Orig2s000_replace_ltr.pdf 10/16/2013
AP010/11/2013N37436000, 204824Orig2s000lbledt.pdf 10/17/2013
AP110/11/2013N37436000, 204824Orig2s000lbledt.pdf 10/17/2013
AP010/11/2013N38432000Orig1 2/3/2014
AP110/11/2013N38432000Orig1 2/3/2014
AP010/11/2013N38433000Orig2 2/3/2014
AP110/11/2013N38433000Orig2 2/3/2014
AP010/11/2013N38451000 2/4/2014
AP110/11/2013N38451000 2/4/2014
AP011/7/2014SCM40975003 11/10/2014
AP011/7/2014SCM40977003 11/12/2014
AP03/24/2016SCM46182004 5/27/2016

Back to FDA Applications sponsored by ANTARES PHARMA INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.